Psychedelics are a risky business
But investors like venture capital firm Palo Santo are diving in

Until recently, scientists who wanted to research psychedelic medicines depended on private philanthropy. Little or no government money was available, and investors were reluctant to support the development of drugs that were stigmatized and illegal.